Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-07

Construction of a mouse model of g6pd deficiency

Ziel



The clinical problem. Glucose-6-phosphate dehydrogenase (G6PD) deficien is the most prevelant human enzymopathy. In its common form it is associated with an acute haemolytic anaemia which may be life threatening, particularily in children. It is also a major cause of neonatal jaundice, which in severe cases can lead to permenant neurological damage.The high frequencies are due to deficient alleles conferring a selective advantage against malaria infection by an unknown mechanism and reach 10% or more in parts of Southern Europe (Greece, Southern Italy). Rarely, G6PD deficiency is the cause of chronic nonspherocytic haemolytic anaemia, which may result in a life-long transfusion requirement.
The overall objectives. The objectives of the present proposal are to gain a better understanding of the molecular pathology of G6PD deficiency by creating an animal model in which a complete study of the molecular disfunctions ocurring in blood, bone marrow and other organs can be assessed. Additionally, this work has clear long term implications for gene therapy.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Daten nicht verfügbar

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

Royal Postgraduate Medical School
EU-Beitrag
Keine Daten
Adresse
150,Du Cane Road
W12 0NN London
Vereinigtes Königreich
Gesamtkosten
Keine Daten

Beteiligte (1)